INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 422m ago
HOUSE PTR22m ago
SEC 13F22m ago
ROBINHOOD CHAIN22m ago
Corporate insider
KM

Kaye Mark

EVP & CFOCIK 0001748691

EDGAR filingsOpen in network
Disclosed transactions15
Buys / sells0 / 13
Max Insider Score34
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$122K
273 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Elevance Health, Inc.EVP & CFO · Oct 6, 2026
24
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL
$245K
560 sh
Oct 22, 2026
Oct 23, 2026
traded Oct 22, 2026
+1d
SEC FORM 4

Evidence

31
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$758K
1,720 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

34
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$1.03M
2,343 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

24
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$212K
480 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

27
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$369K
827 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

24
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$140K
321 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

24
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$105K
240 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

31
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$724K
1,660 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

24
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$174K
400 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

27
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$510K
1,160 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

24
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$195K
440 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

24
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Open-market sale
SELL$71K
160 sh
Oct 22, 2026Oct 23, 2026
traded Oct 22, 2026
+1dSEC FORM 4

Evidence

22
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Tax withholding
F$1.61M
4,161 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC FORM 4

Evidence

13
KM
Kaye MarkEVP & CFO
ELVElevance Health, Inc.
Grant or award
A—
2,627 sh
Oct 2, 2026Oct 6, 2026
traded Oct 2, 2026
+4dSEC FORM 4

Evidence